Form D · Biotechnology
Cyclo Therapeutics, Inc.
Gainsville, FL · CIK 0000922247
Offering snapshot reported Sep 3, 2020 · SEC filing
- Reported sold
- $2.83M Offering amount: $3M
- Investors reported
- 19 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 27, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 3, 2020 | Initial | $2,831,114 | No comparison | 19 | SEC filing |
| Apr 29, 2020 | Initial | $2,000,000 | No comparison | 51 | SEC filing |
| Jun 5, 2019 | Initial | $7,442,500 | No comparison | 50 | SEC filing |
| Dec 28, 2018 | Initial | $2,125,413 | No comparison | 32 | SEC filing |
| Oct 27, 2017 | Initial | $1,500,000 | No comparison | 26 | SEC filing |
| Mar 3, 2017 | Initial | $2,014,191 | No comparison | 37 | SEC filing |
| Jun 13, 2016 | Initial | $2,000,000 | No comparison | 23 | SEC filing |
| Aug 31, 2015 | Initial | $650,000 | No comparison | 6 | SEC filing |
| Jul 23, 2015 | Initial | $1,300,000 | No comparison | 5 | SEC filing |
| Jul 31, 2014 | Initial | $1,725,000 | No comparison | 6 | SEC filing |
| Apr 22, 2014 | Initial | $1,000,000 | No comparison | 1 | SEC filing |
| Mar 3, 2014 | Initial | $500,000 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-374828
Source: Form D, filed Sep 3, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| George Fails | Director |
| Joseph (Judge) J. Farnan | Director |
| Joshua Fine | Executive |
| Nathan Scott Fine | Director, Executive |
| N. Scott Fine | Director |
| Francis Patrick Ostronic | Director |
| F. Patrick Ostronic | Director |
| Markus W. Seiger | Director |
| William S. Shanahan | Director |
| Markus W. Sieger | Director |
| C.E. Rick Strattan | Director |
| C. E. Rick Strattan | Director |
| Jeffrey L. Tate | Director, Executive |
| Randall M. Toig | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
6714 Nw 16 Th Street, Suite B
Gainsville, FL, 32653
Gainsville, FL, 32653